Hidradenitis suppurativa successfully treated with two-stage surgery under disease control with adalimumab

J Dermatol. 2022 Jan;49(1):e1-e2. doi: 10.1111/1346-8138.16143. Epub 2021 Sep 10.

Authors

Akihiro Orita¹, Shinya Kitamura¹, Takuya Maeda¹, Teruki Yanagi¹, Hiroaki Iwata¹, Keiko Shiba-Tokuchi¹, Toshifumi Nomura², Hideyuki Ujiie¹

Affiliations

¹ Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
² Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.

PMID: 34505716
DOI: 10.1111/1346-8138.16143

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adalimumab / therapeutic use
Anti-Inflammatory Agents / therapeutic use
Hidradenitis Suppurativa* / drug therapy
Hidradenitis Suppurativa* / surgery
Humans
Male
Middle Aged

Substances

Anti-Inflammatory Agents
Adalimumab